Anesthesiologists in Oregon may be less likely to make medication mistakes if they use prefilled syringes. Some hospitals are switching to prefilled syringes as a way to save time, money and improve patient safety. At Icahn School of Medicine at Mount Sinai in New York, for example, prefilled ephedrine and neostigmine syringes are used.
Oregon patients might be interested to learn that some hospitals around the country are switching to the use of prefilled syringes over vials of medication in hospital operating rooms. At Boston's Brigham and Women's Hospital, the syringes are in use in the inpatient areas as well. The hospital's director of pharmacy, business and finance reports that the prefilled syringes have cut down on the workload for nurses and saved money. At Icahn School of Medicine at Mount Sinai in New York City, some ORs are hoping prefilled syringes will save money and cut down on costs.
When physicians tell patients in Oregon that fibromyalgia is the source of their pain, they might want to get a second opinion. In an interview published by the National Pain Report, a physician who has been caring for pain patients for two decades said that close to two-thirds of people diagnosed with fibromyalgia do not have the disease.
Oregon women know the importance of getting annual mammograms. However, an Illinois study shows that women who receive a false-positive result are more likely to skip or delay their next screening, which could be a deadly error.
Oregon patients who receive a late diagnosis of cancer may go through unnecessary suffering and many may have an untimely death. In a report released by the World Health Organization, experts are stating that certain actions must be taken to ensure that cancer is detected early.
Oregon patients who are recovering from foot or ankle injuries may be interested to learn that physicians are being advised to opt for additional imaging or second opinions when diagnosing common injuries to these areas. Research showed that when these common areas were misdiagnosed, patients were potentially at risk for poor outcomes that included disability or arthritis.
The prostate-specific antigen test has generally been the standard way for doctors in Oregon and around the country to identify the signs of prostate cancer in older men, but the medical community has started to distance itself from the controversial procedure as questions about its reliability have grown more persistent. Critics of the test point out that it routinely identifies potential cancer in men who are later found to be cancer-free, and they say that this can lead to unnecessary and often debilitating treatment.